Drug intelligence / Profile preview

Equine Pain-Away

Development stage: Unknown
Lead developer: Nutra Pharma
Modality: Peptides
Administration: Topical

Overview

Equine Pain-Away is a homeopathic topical gel developed by Nutra Pharma Corporation for the management of chronic and acute pain in horses. The formulation contains peptides derived from Asian cobra venom (Naja naja) at a 4x homeopathic dilution (30mcg/ml). It is indicated for the temporary relief of joint pain associated with overuse, arthritis, hip dysplasia, and muscle aches. Marketed as a non-narcotic, non-addictive, and NSAID-free alternative, the product is applied topically to affected areas. It was rebranded from Equine Nyloxin and officially launched in October 2019 as an over-the-counter (OTC) veterinary product.

Brand names: Equine Pain-AwayEquine Nyloxin
Other names: Asian cobra venomNaja naja venom

Beyond the preview

Go deeper on Equine Pain-Away.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Equine Pain-Away.

Explore the full profile